Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Core competence back in vogue at AHP - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Mar 22, 2000

    Core competence back in vogue at AHP

    American Home Products (AHP) has announced the sale of its agro–chemical business to BASF AG. Thus AHP would now become a pure health–care company. AHP is represented in India by Wyeth Lederle (healthcare unit) and Cyanamid India (agro–chemicals).

    The agro–chemical scenario the world over has under gone a drastic change over the last year. The agri–business that comprises insecticides, fungicides, and herbicides has itself been restyled as the crop protection business. Genetic seeds, which would not need pesticides were being developed by agro–chemical companies.

    Till last year pharmaceutical companies were considered the prime financers of this revolution. It was in this context that AHP had also tried an unsuccessful merger with Monsanto the agro–chemical major.

    The wheel seems to have come a full circle. International pharmaceutical majors seem to have gone back to the core competence mantra. Novartis, which was formed with the merger of Ciba and Sandoz after the divestment of its chemical business (Clariant) demerged its agro–chemical operations and has recently proposed a merger of its agro–chemical business with Zeneca to form Syngenta. Hoechst Marion Roussel and Rhone Poulenc formed two separate companies Aventis Pharma and Aventis Crop Protection for their pharma and agro–chemical business respectively.

    As far as the Indian operations are concerned the agri–business is concentrated on two crops rice and cotton. With agriculture itself showing marginal growth agro–chemical companies have been facing a tough time.

    The current decision of AHP would lead to another round of re–alignment within the Indian agro–chemical sector. One does not know whether BASF, which has a 100% subsidiary and a listed company BASF Industries would give an open offer to the shareholders of Cyanamid or merge either of its subsidiaries with Cyanamid.



    Equitymaster requests your view! Post a comment on "Core competence back in vogue at AHP". Click here!


    More Views on News

    Sorry! There are no related views on news for this company/sector.

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    • Track your investment in CYANAMID AGR with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks